Company Description
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.
The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.
It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform.
The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015.
Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
| Country | United States |
| Founded | 2003 |
| IPO Date | Sep 15, 2020 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 480 |
| CEO | Leslie Trigg |
Contact Details
Address: 3052 Orchard Drive San Jose, California 95134 United States | |
| Phone | 669 231 8200 |
| Website | outsetmedical.com |
Stock Details
| Ticker Symbol | OM |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $27.00 |
| CIK Code | 0001484612 |
| CUSIP Number | 690145107 |
| ISIN Number | US6901451079 |
| Employer ID | 20-0514392 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Leslie L. Trigg | President, Chief Executive Officer and Chairman |
| Nabeel Ahmed | Chief Financial Officer |
| John L. Brottem J.D. | General Counsel and Secretary |
| Marc Nash | Senior Vice President of Operations and Research & Development |
| James S. Mazzola | Head of Investor Relations |
| Laura Romike | Senior Vice President of Sales |
| Amelia Merrill | Vice President of People Operations and Culture |
| Dr. Michael Aragon M.D. | Chief Medical Officer |
| Jennifer Sipple | Senior Vice President of Customer Experience |
| Dinamarie Stefani | Senior Vice President of Regulatory Affairs and Quality Assurance |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 20, 2025 | 8-K | Current Report |
| Mar 18, 2025 | 8-K | Current Report |
| Mar 17, 2025 | SCHEDULE 13G | Filing |
| Mar 11, 2025 | 8-K | Current Report |
| Mar 6, 2025 | 8-K | Current Report |
| Feb 28, 2025 | EFFECT | Notice of Effectiveness |
| Feb 28, 2025 | SCHEDULE 13G | Filing |
| Feb 28, 2025 | 424B3 | Prospectus |
| Feb 28, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 28, 2025 | 10-K | Annual Report |